It has been shown that
epitopes reactive with one group of rabbit
antibodies to human
fibrinopeptide A (
hFPA, A alpha 1-16) are included in its COOH-terminal region (A alpha 7-16). It was further established that Asp-7, Phe-8, and Arg-16 contribute to immunoreactivity and that intact
fibrinogen and
hFPA-containing fragments react poorly with such
antibodies. The purpose of this investigation was to prepare a synthetic
peptide corresponding to A alpha 7-16 and use it for generation of FPA-specific
monoclonal antibodies (MoAbs). Such probes would allow for development of assays that could measure
hFPA directly in plasma. In our approach, an
ovalbumin-conjugate of the
hFPA homologue served as immunogen. Mouse spleen cells were fused with the
immunoglobulin nonsecretor myeloma (P3X63Ag8.653). A hybridoma (8C2-5) has been isolated that secretes an antibody (MoAb/8C2-5) with the following characteristics: (a)
IgG1, kappa isotype; (b) equilibrium dissociation constant of 1.5 +/- 0.2 x 10(7) L/mol with the [125I]-labeled N-tyrosyl derivative of
hFPA [( 125I] Tyr-
hFPA) as
ligand; (c) reacts with
hFPA and dog FPA (
dFPA) but not with the des Arg (A alpha 1-15) or shorter
peptides; (d) does not react with intact
fibrinogen or A alpha-chain of human or dog origin; (e) does not react with the
elastase-generated
hFPA-containing
peptide A alpha 1-21.
Enzyme-based immunoassays (EIAs) have been developed for measuring plasma
hFPA levels in the range 3 x 10(-8) to 5 x 10(-7) mol/L. Since it has already been shown by a number of investigators that
hFPA levels in patients with overt defibrination fall into this range, we propose that the MoAb/8C2-5-based assays may serve as useful clinical tools in screening patients at risk of
thrombosis. The 8C2-5 antibody may also be helpful in studies dealing with congenital dysfibrinogenemias, particularly in identifying heterozygous propositi with amino acid substitutions at any position within the A alpha 7-16 region. Finally, due to its cross-reactivity with
dFPA, assays using this antibody should also be valuable in the canine experimental
thrombosis model studies.